Welcome to CDC Stacks | Extensively drug-resistant tuberculosis; (XDR TB) - 5882 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Extensively drug-resistant tuberculosis; (XDR TB)
  • Published Date:
    February 2009
Filetype[PDF - 326.24 KB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
  • Description:
    "Extensively drug-resistant tuberculosis (XDR TB) is a relatively rare type of multidrug-resistant tuberculosis (MDR TB). It is resistant to almost all drugs used to treat TB, including the two best first-line drugs: isoniazid and rifampin. XDR TB is also resistant to the best second-line medications: fluoroquinolones and at least one of three injectable drugs (i.e., amikacin, kanamycin, or capreomycin). (World Health Organization [WHO] definition for cases detected on initial susceptibility testing.)." - p. 1

  • Place as Subject:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: